Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation

Transplant Proc. 2002 Aug;34(5):1906-8. doi: 10.1016/s0041-1345(02)03118-4.

Authors

Paolo Rigotti¹, N Baldan, R Cadrobbi, L Furian, G Sarzo, L Dall'Olmo, E Ancona

Affiliation

¹ Clinica Chirurgica IV, Department of Medical and Surgical Sciences, Ospedale Giustinianeo, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.

PMID: 12176623
DOI: 10.1016/s0041-1345(02)03118-4

No abstract available

MeSH terms

Adult
Antilymphocyte Serum / therapeutic use*
Diabetes Mellitus, Type 1 / surgery
Diabetic Nephropathies / surgery
Drug Therapy, Combination
Graft Survival / physiology
Humans
Immunosuppression Therapy / methods
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / surgery
Kidney Transplantation / immunology*
Kidney Transplantation / mortality
Kidney Transplantation / physiology
Middle Aged
Pancreas Transplantation / immunology*
Pancreas Transplantation / mortality
Pancreas Transplantation / physiology
Survival Rate
Tacrolimus / therapeutic use
Time Factors

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Tacrolimus